<!DOCTYPE HTML>

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
  <title>Intersection of eclaire-study-phase-source-code-system and eclaire-study-phase-source-code-system</title>
 <link rel="stylesheet" href="fhir.css"/>
</head>
<body>

<h2>Intersection of https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system and https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</h2>

<p>
  This is the CodeSystem that contains codes in both Définition des phase de l'essai utilisés dans la base de données ECLAIRE (https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system) and Définition des phase de l'essai utilisés dans la base de données ECLAIRE (https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system).
</table>

<h3>Structure</h3>

<div><p class="res-header-id"><b>Generated Narrative: CodeSystem 14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24</b></p><a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24"> </a><a name="hc14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24"> </a><a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-fr-FR"> </a><p>This  code system <code>http://hl7.org/fhir/comparison/CodeSystem/14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24</code> defines codes, but no codes are represented here</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">jarde-early<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-jarde-early"> </a></td><td>Jardé phase précoce</td></tr><tr><td style="white-space:nowrap">phase-I-first-admin<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-first-admin"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-bioequivalence<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-bioequivalence"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-other<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-other"> </a></td><td>Human Pharmacology (Phase I) -  Other</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-admin<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-II-first-admin"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-bioequivalence<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-II-first-bioequivalence"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-II-other<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-I-II-other"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style="white-space:nowrap">phase-II<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-II"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style="white-space:nowrap">phase-II-III<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-II-III"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style="white-space:nowrap">phase-III<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-III"> </a></td><td>Therapeutic confirmatory  (Phase III)</td></tr><tr><td style="white-space:nowrap">phase-IV<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-IV"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style="white-space:nowrap">phase-III-IV<a name="14c28dfb-cf83-4ef5-b2f8-d9781464eacd-24-phase-III-IV"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>

</body>
</html>

<ul>
</ul>
